October 27, 2020 Comments Off on New patent for Epizyme Inc drug TAZVERIK Posted in: Patent Added Annual Drug Patent Expirations for TAZVERIK Tazverik is a drug marketed by Epizyme Inc and is included in one NDA. There are twenty patents protecting this drug. This drug has…
The post New patent for Epizyme Inc drug TAZVERIK appeared first on DrugPat…
October 27, 2020 Comments Off on New patent for Loxo Oncology drug RETEVMO Posted in: Patent Added Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncology Inc and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Loxo Oncology drug RETEVMO appeared first on DrugPatentWat…